Clopidogrel Bisulfate Tablet, Film Coated
Product Images NDC 82009-182

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Clopidogrel Bisulfate (NDC 82009-182). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container1 (Container1)

Label for Clopidogrel Tablets, USP 75 mg, film-coated tablets in a 90-count package. The label includes dosage strength, NDC 82009-182-90, and manufacturer information for Quallent Pharmaceuticals Health LLC. Additional text presents dosage instructions and storage conditions.*

FDA Label Image

Figure1 (Figure1)

A scatter plot with horizontal error bars illustrating the effect of co-administered proton pump inhibitors (PPIs) on the active metabolite area under the curve (AUC). The PPIs included are Dexlansoprazole 60 mg, Lansoprazole 30 mg, Pantoprazole 80 mg, and Omeprazole 80 mg, with mean values and 90% confidence intervals shown along an AUC scale from 0.4 to 1.4.*

FDA Label Image

Figure2 (Figure2)

A chart depicting the cumulative event rate (%) over 12 months of follow-up comparing Clopidogrel plus aspirin to placebo plus aspirin. The Clopidogrel (+ aspirin) line shows a lower cumulative event rate compared to placebo (+ aspirin) throughout the observed period.*

FDA Label Image

Figure3 (Figure3)

A forest plot chart showing subgroup analyses of Clopidogrel bisulfate versus placebo. The chart presents different patient subgroups based on age, gender, race, cardiovascular history, comedications, and more, with hazard ratios and 95% confidence intervals indicating the comparative outcomes between Clopidogrel and placebo groups.*

FDA Label Image

Figure4 (Figure4)

A Kaplan-Meier survival curve comparing the percentage of deaths before first discharge between Clopidogrel and placebo groups over 28 days since randomization. The graph shows cumulative percent dead on the y-axis and days since randomization on the x-axis, with annotations indicating death counts and a 7% proportional risk reduction favoring Clopidogrel.*

FDA Label Image

Figure5 (Figure5)

A line graph showing the percentage of subjects with death, reinfarction, or stroke before first discharge over 28 days since randomization. It compares outcomes between placebo and clopidogrel groups, indicating a 9% proportional risk reduction with clopidogrel (p=0.002).*

FDA Label Image

Figure6 (Figure6)

A forest plot showing odds ratios (99% confidence intervals) comparing Clopidogrel versus placebo across various subgroups. Subgroups include gender, age at entry, hours since onset, systolic blood pressure, heart rate, and fibrinolytic agent use. Each subgroup lists number of participants (N) and percentage experiencing the outcome for Clopidogrel and placebo groups.*

FDA Label Image

Figure7 (Figure7)

A line graph showing cumulative event rates (%) of fatal or non-fatal vascular events over 36 months of follow-up. Two lines compare aspirin and clopidogrel, with clopidogrel showing a slightly lower cumulative event rate. The graph includes a p-value of 0.045.*

FDA Label Image

Figure8 (Figure8)

A forest plot showing hazard ratios comparing Clopidogrel and Aspirin across different qualifying conditions: Stroke, MI, PAD, and Overall. The chart visually represents which treatment is favored for each condition, with hazard ratios and confidence intervals plotted on a horizontal axis ranging approximately from 0.6 to 1.3.*

FDA Label Image

Structure (Structure)

Chemical structure of clopidogrel bisulfate, showing its molecular components and arrangement including a thiophene ring, a bicyclic structure, methoxy, and chlorine substituents, depicted alongside sulfate (H2SO4).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.